Tag Archives: pharmaceuticals

What’s driving your pharmacy costs?

Increased demand for prescription drugs, expensive specialty medicines, price inflation and widespread chronic illness are causing a greater strain on health plan and patient pharmacy resources. To more effectively manage these costs, plans need to understand the drivers of their trend, identify actionable data and consider a multi-pronged approach to control spend while deriving value. […]
Read More »

A look back at the ISPOR Annual International Meeting

Last week, participants from across our enterprise gathered in Philadelphia to contribute to the 20th Annual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) conference. ISPOR advances the policy, science, and practice of pharmacoeconomics (or health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being, including […]
Read More »

The Power of Real-World Evidence

Next week, May 16 – 20, Optum colleagues, clients, industry peers, global researchers and thought leaders are gathering in Philadelphia at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) 20th Annual International Meeting. I’m looking forward to convening with our clients, discussing our progress and brainstorming about the new challenges to be tackled. Reflecting […]
Read More »

What’s the “Best” Data?–The Data That Can Answer the Question!

In a previous post by my colleague Dr. Aylin Altan Riedel, she presented an overview of Analyze This!, an educational symposium sponsored by Optum Life Sciences at the 18th Annual International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting. I’m pleased to be a part of this panel discussion focused on getting the […]
Read More »

Analyze This! ISPOR panel to discuss Big Data, The Cloud and Real World Evidence

Each year at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting, the Optum Life Sciences group hosts an educational symposium before the attending global researchers and thought leaders. At this year’s 18th ISPOR gathering, I’m pleased to moderate an important educational symposium to be held tomorrow titled, “Analyze This! Getting the […]
Read More »

ISPOR: Focusing on the Patient

For the past 17 years, attendance at the International Society of Pharmacoeconomics and Outcomes Research (ISPOR) Annual International Meeting has grown from under 500 in attendance at the first conference held in 1996 to an expected turnout of more than 3,000 during the May 18-22, 2013 meeting in New Orleans.

Do You Hate to be Late? Most People Do

In most every aspect of our lives, it pays to be on time. This is especially true for pharmaceutical companies under pressure to complete clinical trials quickly and effectively so they can bring new drugs to market sooner. Unfortunately, clinical trials often are subject to costly delays, caused by the challenges inherent in finding the […]
Read More »